Next Article in Journal
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
Next Article in Special Issue
Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
Previous Article in Journal
The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
Previous Article in Special Issue
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines
 
 
Article

Article Versions Notes

Cancers 2018, 10(8), 243; https://doi.org/10.3390/cancers10080243
Action Date Notes Link
article xml file uploaded 25 July 2018 06:14 CEST Original file -
article xml uploaded. 25 July 2018 06:14 CEST Update https://www.mdpi.com/2072-6694/10/8/243/xml
article pdf uploaded. 25 July 2018 06:14 CEST Version of Record https://www.mdpi.com/2072-6694/10/8/243/pdf
article supplementary file uploaded. 25 July 2018 06:14 CEST - https://www.mdpi.com/2072-6694/10/8/243#supplementary
article html file updated 25 July 2018 06:15 CEST Original file -
article html file updated 2 August 2018 16:00 CEST Update -
article html file updated 28 August 2018 04:50 CEST Update -
article html file updated 30 March 2019 23:53 CET Update -
article html file updated 15 April 2019 18:41 CEST Update -
article html file updated 29 April 2019 23:30 CEST Update -
article html file updated 5 October 2019 23:03 CEST Update -
article html file updated 10 February 2020 02:50 CET Update -
article html file updated 16 July 2022 23:45 CEST Update https://www.mdpi.com/2072-6694/10/8/243/html
Back to TopTop